Cover Image
Market Research Report
Product code 
1052175

Global Erythropoietin Drugs Market Insights and Forecast to 2028

Published: | QYResearch | 93 Pages | Delivery time: 2-3 business days

Price

Back to Top
Global Erythropoietin Drugs Market Insights and Forecast to 2028
Published: January 20, 2022
QYResearch
Content info: 93 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule.

Market Analysis and Insights: Global Erythropoietin Drugs Market

Due to the COVID-19 pandemic, the global Erythropoietin Drugs market size is estimated to be worth US$ 9734.1 million in 2022 and is forecast to a readjusted size of US$ 13560 million by 2028 with a CAGR of 5.7% during the review period. Fully considering the economic change by this health crisis, Epoetin-alfa accounting for % of the Erythropoietin Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Anemia segment is altered to an % CAGR throughout this forecast period.

The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of retail pharmacies to provide a large customer base for biosimilars coupled with the requirement from anemic patients for EPO drugs as a maintenance therapy is the key contributor to the dominance of this segment in the global market.

Global Erythropoietin Drugs Scope and Segment

Erythropoietin Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Erythropoietin Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Epoetin-alfa
  • Darbepoetin-alfa
  • Epoetin-beta
  • Others

Segment by Application

  • Anemia
  • Kidney Disorders
  • Other

By Company

  • Amgen
  • Johnson & Johnson
  • Roche
  • Galenica
  • Emcure
  • Kyowa Hakko Kirin
  • 3SBio
  • Biocon
  • LG Life Sciences

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Erythropoietin Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Erythropoietin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Epoetin-alfa
    • 1.2.3 Darbepoetin-alfa
    • 1.2.4 Epoetin-beta
    • 1.2.5 Others
  • 1.3 Market by Application
    • 1.3.1 Global Erythropoietin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Anemia
    • 1.3.3 Kidney Disorders
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Erythropoietin Drugs Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Erythropoietin Drugs Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Erythropoietin Drugs Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Erythropoietin Drugs Sales by Region
    • 2.4.1 Global Erythropoietin Drugs Sales by Region (2017-2022)
    • 2.4.2 Global Sales Erythropoietin Drugs by Region (2023-2028)
  • 2.5 Global Erythropoietin Drugs Revenue by Region
    • 2.5.1 Global Erythropoietin Drugs Revenue by Region (2017-2022)
    • 2.5.2 Global Erythropoietin Drugs Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Erythropoietin Drugs Sales by Manufacturers
    • 3.1.1 Global Top Erythropoietin Drugs Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Erythropoietin Drugs Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Erythropoietin Drugs in 2021
  • 3.2 Global Erythropoietin Drugs Revenue by Manufacturers
    • 3.2.1 Global Erythropoietin Drugs Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Erythropoietin Drugs Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Erythropoietin Drugs Revenue in 2021
  • 3.3 Global Erythropoietin Drugs Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Erythropoietin Drugs Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Erythropoietin Drugs Sales by Type
    • 4.1.1 Global Erythropoietin Drugs Historical Sales by Type (2017-2022)
    • 4.1.2 Global Erythropoietin Drugs Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • 4.2 Global Erythropoietin Drugs Revenue by Type
    • 4.2.1 Global Erythropoietin Drugs Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Erythropoietin Drugs Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • 4.3 Global Erythropoietin Drugs Price by Type
    • 4.3.1 Global Erythropoietin Drugs Price by Type (2017-2022)
    • 4.3.2 Global Erythropoietin Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Erythropoietin Drugs Sales by Application
    • 5.1.1 Global Erythropoietin Drugs Historical Sales by Application (2017-2022)
    • 5.1.2 Global Erythropoietin Drugs Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • 5.2 Global Erythropoietin Drugs Revenue by Application
    • 5.2.1 Global Erythropoietin Drugs Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Erythropoietin Drugs Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • 5.3 Global Erythropoietin Drugs Price by Application
    • 5.3.1 Global Erythropoietin Drugs Price by Application (2017-2022)
    • 5.3.2 Global Erythropoietin Drugs Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Erythropoietin Drugs Market Size by Type
    • 6.1.1 North America Erythropoietin Drugs Sales by Type (2017-2028)
    • 6.1.2 North America Erythropoietin Drugs Revenue by Type (2017-2028)
  • 6.2 North America Erythropoietin Drugs Market Size by Application
    • 6.2.1 North America Erythropoietin Drugs Sales by Application (2017-2028)
    • 6.2.2 North America Erythropoietin Drugs Revenue by Application (2017-2028)
  • 6.3 North America Erythropoietin Drugs Market Size by Country
    • 6.3.1 North America Erythropoietin Drugs Sales by Country (2017-2028)
    • 6.3.2 North America Erythropoietin Drugs Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Erythropoietin Drugs Market Size by Type
    • 7.1.1 Europe Erythropoietin Drugs Sales by Type (2017-2028)
    • 7.1.2 Europe Erythropoietin Drugs Revenue by Type (2017-2028)
  • 7.2 Europe Erythropoietin Drugs Market Size by Application
    • 7.2.1 Europe Erythropoietin Drugs Sales by Application (2017-2028)
    • 7.2.2 Europe Erythropoietin Drugs Revenue by Application (2017-2028)
  • 7.3 Europe Erythropoietin Drugs Market Size by Country
    • 7.3.1 Europe Erythropoietin Drugs Sales by Country (2017-2028)
    • 7.3.2 Europe Erythropoietin Drugs Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Erythropoietin Drugs Market Size by Type
    • 8.1.1 Asia Pacific Erythropoietin Drugs Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Erythropoietin Drugs Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Erythropoietin Drugs Market Size by Application
    • 8.2.1 Asia Pacific Erythropoietin Drugs Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Erythropoietin Drugs Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Erythropoietin Drugs Market Size by Region
    • 8.3.1 Asia Pacific Erythropoietin Drugs Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Erythropoietin Drugs Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Erythropoietin Drugs Market Size by Type
    • 9.1.1 Latin America Erythropoietin Drugs Sales by Type (2017-2028)
    • 9.1.2 Latin America Erythropoietin Drugs Revenue by Type (2017-2028)
  • 9.2 Latin America Erythropoietin Drugs Market Size by Application
    • 9.2.1 Latin America Erythropoietin Drugs Sales by Application (2017-2028)
    • 9.2.2 Latin America Erythropoietin Drugs Revenue by Application (2017-2028)
  • 9.3 Latin America Erythropoietin Drugs Market Size by Country
    • 9.3.1 Latin America Erythropoietin Drugs Sales by Country (2017-2028)
    • 9.3.2 Latin America Erythropoietin Drugs Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Erythropoietin Drugs Market Size by Type
    • 10.1.1 Middle East and Africa Erythropoietin Drugs Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Erythropoietin Drugs Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Erythropoietin Drugs Market Size by Application
    • 10.2.1 Middle East and Africa Erythropoietin Drugs Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Erythropoietin Drugs Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Erythropoietin Drugs Market Size by Country
    • 10.3.1 Middle East and Africa Erythropoietin Drugs Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Erythropoietin Drugs Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Amgen
    • 11.1.1 Amgen Corporation Information
    • 11.1.2 Amgen Overview
    • 11.1.3 Amgen Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Amgen Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Amgen Recent Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Johnson & Johnson Corporation Information
    • 11.2.2 Johnson & Johnson Overview
    • 11.2.3 Johnson & Johnson Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Johnson & Johnson Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Johnson & Johnson Recent Developments
  • 11.3 Roche
    • 11.3.1 Roche Corporation Information
    • 11.3.2 Roche Overview
    • 11.3.3 Roche Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Roche Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Roche Recent Developments
  • 11.4 Galenica
    • 11.4.1 Galenica Corporation Information
    • 11.4.2 Galenica Overview
    • 11.4.3 Galenica Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 Galenica Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Galenica Recent Developments
  • 11.5 Emcure
    • 11.5.1 Emcure Corporation Information
    • 11.5.2 Emcure Overview
    • 11.5.3 Emcure Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Emcure Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Emcure Recent Developments
  • 11.6 Kyowa Hakko Kirin
    • 11.6.1 Kyowa Hakko Kirin Corporation Information
    • 11.6.2 Kyowa Hakko Kirin Overview
    • 11.6.3 Kyowa Hakko Kirin Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Kyowa Hakko Kirin Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Kyowa Hakko Kirin Recent Developments
  • 11.7 3SBio
    • 11.7.1 3SBio Corporation Information
    • 11.7.2 3SBio Overview
    • 11.7.3 3SBio Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 3SBio Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 3SBio Recent Developments
  • 11.8 Biocon
    • 11.8.1 Biocon Corporation Information
    • 11.8.2 Biocon Overview
    • 11.8.3 Biocon Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Biocon Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Biocon Recent Developments
  • 11.9 LG Life Sciences
    • 11.9.1 LG Life Sciences Corporation Information
    • 11.9.2 LG Life Sciences Overview
    • 11.9.3 LG Life Sciences Erythropoietin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 LG Life Sciences Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 LG Life Sciences Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Erythropoietin Drugs Industry Chain Analysis
  • 12.2 Erythropoietin Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Erythropoietin Drugs Production Mode & Process
  • 12.4 Erythropoietin Drugs Sales and Marketing
    • 12.4.1 Erythropoietin Drugs Sales Channels
    • 12.4.2 Erythropoietin Drugs Distributors
  • 12.5 Erythropoietin Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Erythropoietin Drugs Industry Trends
  • 13.2 Erythropoietin Drugs Market Drivers
  • 13.3 Erythropoietin Drugs Market Challenges
  • 13.4 Erythropoietin Drugs Market Restraints

14 Key Findings in The Global Erythropoietin Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

LIST OF TABLES

List of Tables

  • Table 1. Global Erythropoietin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Epoetin-alfa
  • Table 3. Major Manufacturers of Darbepoetin-alfa
  • Table 4. Major Manufacturers of Epoetin-beta
  • Table 5. Major Manufacturers of Others
  • Table 6. Global Erythropoietin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Erythropoietin Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 8. Global Erythropoietin Drugs Sales by Region (2017-2022) & (K Pcs)
  • Table 9. Global Erythropoietin Drugs Sales Market Share by Region (2017-2022)
  • Table 10. Global Erythropoietin Drugs Sales by Region (2023-2028) & (K Pcs)
  • Table 11. Global Erythropoietin Drugs Sales Market Share by Region (2023-2028)
  • Table 12. Global Erythropoietin Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 13. Global Erythropoietin Drugs Revenue Market Share by Region (2017-2022)
  • Table 14. Global Erythropoietin Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 15. Global Erythropoietin Drugs Revenue Market Share by Region (2023-2028)
  • Table 16. Global Erythropoietin Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
  • Table 17. Global Erythropoietin Drugs Sales Share by Manufacturers (2017-2022)
  • Table 18. Global Erythropoietin Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 19. Global Erythropoietin Drugs Revenue Share by Manufacturers (2017-2022)
  • Table 20. Erythropoietin Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
  • Table 21. Global Erythropoietin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Erythropoietin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erythropoietin Drugs as of 2021)
  • Table 23. Erythropoietin Drugs Manufacturing Base Distribution and Headquarters
  • Table 24. Manufacturers Erythropoietin Drugs Product Offered
  • Table 25. Date of Manufacturers Enter into Erythropoietin Drugs Market
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 28. Global Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 29. Global Erythropoietin Drugs Sales Share by Type (2017-2022)
  • Table 30. Global Erythropoietin Drugs Sales Share by Type (2023-2028)
  • Table 31. Global Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 32. Global Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 33. Global Erythropoietin Drugs Revenue Share by Type (2017-2022)
  • Table 34. Global Erythropoietin Drugs Revenue Share by Type (2023-2028)
  • Table 35. Erythropoietin Drugs Price by Type (2017-2022) & (USD/Pcs)
  • Table 36. Global Erythropoietin Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
  • Table 37. Global Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 38. Global Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 39. Global Erythropoietin Drugs Sales Share by Application (2017-2022)
  • Table 40. Global Erythropoietin Drugs Sales Share by Application (2023-2028)
  • Table 41. Global Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 42. Global Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 43. Global Erythropoietin Drugs Revenue Share by Application (2017-2022)
  • Table 44. Global Erythropoietin Drugs Revenue Share by Application (2023-2028)
  • Table 45. Erythropoietin Drugs Price by Application (2017-2022) & (USD/Pcs)
  • Table 46. Global Erythropoietin Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
  • Table 47. North America Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 48. North America Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 49. North America Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 50. North America Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 51. North America Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 52. North America Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 53. North America Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 54. North America Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 55. North America Erythropoietin Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 56. North America Erythropoietin Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 57. North America Erythropoietin Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 58. North America Erythropoietin Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 59. Europe Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 60. Europe Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 61. Europe Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 62. Europe Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 63. Europe Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 64. Europe Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 65. Europe Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 66. Europe Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 67. Europe Erythropoietin Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 68. Europe Erythropoietin Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 69. Europe Erythropoietin Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 70. Europe Erythropoietin Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 71. Asia Pacific Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 72. Asia Pacific Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 73. Asia Pacific Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 74. Asia Pacific Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 75. Asia Pacific Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 76. Asia Pacific Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 77. Asia Pacific Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 78. Asia Pacific Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 79. Asia Pacific Erythropoietin Drugs Sales by Region (2017-2022) & (K Pcs)
  • Table 80. Asia Pacific Erythropoietin Drugs Sales by Region (2023-2028) & (K Pcs)
  • Table 81. Asia Pacific Erythropoietin Drugs Revenue by Region (2017-2022) & (US$ Million)
  • Table 82. Asia Pacific Erythropoietin Drugs Revenue by Region (2023-2028) & (US$ Million)
  • Table 83. Latin America Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 84. Latin America Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 85. Latin America Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 86. Latin America Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 87. Latin America Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 88. Latin America Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 89. Latin America Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 90. Latin America Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 91. Latin America Erythropoietin Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 92. Latin America Erythropoietin Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 93. Latin America Erythropoietin Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 94. Latin America Erythropoietin Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 95. Middle East and Africa Erythropoietin Drugs Sales by Type (2017-2022) & (K Pcs)
  • Table 96. Middle East and Africa Erythropoietin Drugs Sales by Type (2023-2028) & (K Pcs)
  • Table 97. Middle East and Africa Erythropoietin Drugs Revenue by Type (2017-2022) & (US$ Million)
  • Table 98. Middle East and Africa Erythropoietin Drugs Revenue by Type (2023-2028) & (US$ Million)
  • Table 99. Middle East and Africa Erythropoietin Drugs Sales by Application (2017-2022) & (K Pcs)
  • Table 100. Middle East and Africa Erythropoietin Drugs Sales by Application (2023-2028) & (K Pcs)
  • Table 101. Middle East and Africa Erythropoietin Drugs Revenue by Application (2017-2022) & (US$ Million)
  • Table 102. Middle East and Africa Erythropoietin Drugs Revenue by Application (2023-2028) & (US$ Million)
  • Table 103. Middle East and Africa Erythropoietin Drugs Sales by Country (2017-2022) & (K Pcs)
  • Table 104. Middle East and Africa Erythropoietin Drugs Sales by Country (2023-2028) & (K Pcs)
  • Table 105. Middle East and Africa Erythropoietin Drugs Revenue by Country (2017-2022) & (US$ Million)
  • Table 106. Middle East and Africa Erythropoietin Drugs Revenue by Country (2023-2028) & (US$ Million)
  • Table 107. Amgen Corporation Information
  • Table 108. Amgen Description and Major Businesses
  • Table 109. Amgen Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 110. Amgen Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Amgen Recent Developments
  • Table 112. Johnson & Johnson Corporation Information
  • Table 113. Johnson & Johnson Description and Major Businesses
  • Table 114. Johnson & Johnson Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 115. Johnson & Johnson Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Johnson & Johnson Recent Developments
  • Table 117. Roche Corporation Information
  • Table 118. Roche Description and Major Businesses
  • Table 119. Roche Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 120. Roche Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Roche Recent Developments
  • Table 122. Galenica Corporation Information
  • Table 123. Galenica Description and Major Businesses
  • Table 124. Galenica Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 125. Galenica Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Galenica Recent Developments
  • Table 127. Emcure Corporation Information
  • Table 128. Emcure Description and Major Businesses
  • Table 129. Emcure Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 130. Emcure Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Emcure Recent Developments
  • Table 132. Kyowa Hakko Kirin Corporation Information
  • Table 133. Kyowa Hakko Kirin Description and Major Businesses
  • Table 134. Kyowa Hakko Kirin Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 135. Kyowa Hakko Kirin Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Kyowa Hakko Kirin Recent Developments
  • Table 137. 3SBio Corporation Information
  • Table 138. 3SBio Description and Major Businesses
  • Table 139. 3SBio Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 140. 3SBio Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. 3SBio Recent Developments
  • Table 142. Biocon Corporation Information
  • Table 143. Biocon Description and Major Businesses
  • Table 144. Biocon Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 145. Biocon Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Biocon Recent Developments
  • Table 147. LG Life Sciences Corporation Information
  • Table 148. LG Life Sciences Description and Major Businesses
  • Table 149. LG Life Sciences Erythropoietin Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
  • Table 150. LG Life Sciences Erythropoietin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. LG Life Sciences Recent Developments
  • Table 152. Key Raw Materials Lists
  • Table 153. Raw Materials Key Suppliers Lists
  • Table 154. Erythropoietin Drugs Distributors List
  • Table 155. Erythropoietin Drugs Customers List
  • Table 156. Erythropoietin Drugs Market Trends
  • Table 157. Erythropoietin Drugs Market Drivers
  • Table 158. Erythropoietin Drugs Market Challenges
  • Table 159. Erythropoietin Drugs Market Restraints
  • Table 160. Research Programs/Design for This Report
  • Table 161. Key Data Information from Secondary Sources
  • Table 162. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Erythropoietin Drugs Product Picture
  • Figure 3. Global Erythropoietin Drugs Market Share by Type in 2021 & 2028
  • Figure 3. Epoetin-alfa Product Picture
  • Figure 4. Darbepoetin-alfa Product Picture
  • Figure 5. Epoetin-beta Product Picture
  • Figure 6. Others Product Picture
  • Figure 7. Global Erythropoietin Drugs Market Share by Application in 2021 & 2028
  • Figure 8. Anemia
  • Figure 9. Kidney Disorders
  • Figure 10. Other
  • Figure 11. Erythropoietin Drugs Report Years Considered
  • Figure 12. Global Erythropoietin Drugs Sales 2017-2028 (K Pcs)
  • Figure 13. Global Erythropoietin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Erythropoietin Drugs Revenue 2017-2028 (US$ Million)
  • Figure 15. Global Erythropoietin Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 16. Global Erythropoietin Drugs Sales Market Share by Region (2017-2022)
  • Figure 17. Global Erythropoietin Drugs Sales Market Share by Region (2023-2028)
  • Figure 18. North America Erythropoietin Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 19. North America Erythropoietin Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Europe Erythropoietin Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 21. Europe Erythropoietin Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Asia-Pacific Erythropoietin Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 23. Asia-Pacific Erythropoietin Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Latin America Erythropoietin Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 25. Latin America Erythropoietin Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. Middle East & Africa Erythropoietin Drugs Sales YoY (2017-2028) & (K Pcs)
  • Figure 27. Middle East & Africa Erythropoietin Drugs Revenue YoY (2017-2028) & (US$ Million)
  • Figure 28. The Erythropoietin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Erythropoietin Drugs in the World: Market Share by Erythropoietin Drugs Revenue in 2021
  • Figure 30. Global Erythropoietin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 31. Global Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 32. Global Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 33. Global Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 34. Global Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 35. North America Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 36. North America Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 37. North America Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 38. North America Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 39. North America Erythropoietin Drugs Sales Share by Country (2017-2028)
  • Figure 40. North America Erythropoietin Drugs Revenue Share by Country (2017-2028)
  • Figure 41. U.S. Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 42. Canada Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 43. Europe Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 44. Europe Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 45. Europe Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 46. Europe Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 47. Europe Erythropoietin Drugs Sales Share by Country (2017-2028)
  • Figure 48. Europe Erythropoietin Drugs Revenue Share by Country (2017-2028)
  • Figure 49. Germany Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 50. France Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 51. U.K. Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 52. Italy Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 53. Russia Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 54. Asia Pacific Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 56. Asia Pacific Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 58. Asia Pacific Erythropoietin Drugs Sales Share by Region (2017-2028)
  • Figure 59. Asia Pacific Erythropoietin Drugs Revenue Share by Region (2017-2028)
  • Figure 60. China Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 61. Japan Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 62. South Korea Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 63. India Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 64. Australia Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 65. Taiwan Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 66. Indonesia Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 67. Thailand Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 68. Malaysia Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 69. Philippines Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 70. Latin America Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 71. Latin America Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 72. Latin America Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 73. Latin America Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 74. Latin America Erythropoietin Drugs Sales Share by Country (2017-2028)
  • Figure 75. Latin America Erythropoietin Drugs Revenue Share by Country (2017-2028)
  • Figure 76. Mexico Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 77. Brazil Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 78. Argentina Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 79. Middle East and Africa Erythropoietin Drugs Sales Market Share by Type (2017-2028)
  • Figure 80. Middle East and Africa Erythropoietin Drugs Revenue Market Share by Type (2017-2028)
  • Figure 81. Middle East and Africa Erythropoietin Drugs Sales Market Share by Application (2017-2028)
  • Figure 82. Middle East and Africa Erythropoietin Drugs Revenue Market Share by Application (2017-2028)
  • Figure 83. Middle East and Africa Erythropoietin Drugs Sales Share by Country (2017-2028)
  • Figure 84. Middle East and Africa Erythropoietin Drugs Revenue Share by Country (2017-2028)
  • Figure 85. Turkey Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 86. Saudi Arabia Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 87. UAE Erythropoietin Drugs Revenue (2017-2028) & (US$ Million)
  • Figure 88. Erythropoietin Drugs Value Chain
  • Figure 89. Erythropoietin Drugs Production Process
  • Figure 90. Channels of Distribution
  • Figure 91. Distributors Profiles
  • Figure 92. Bottom-up and Top-down Approaches for This Report
  • Figure 93. Data Triangulation
  • Figure 94. Key Executives Interviewed